Position in ZVRA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,531,645
-$162,212 QoQ
Shares Held
378,932
-8.1% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 86.88075960858413.ToString("F0")%
Shared 0.ToString("F0")%
None 13.119240391415874.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ZVRA ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ZVRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,531,645 | 378,932 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,693,857 | 412,261 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,174,736 | 438,984 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $248,097 | 28,161 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $218,242 | 29,138 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $229,265 | 27,490 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $126,759 | 18,265 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $91,457 | 18,665 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $87,352 | 15,061 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $176,154 | 26,894 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $112,126 | 23,263 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $141,136 | 27,674 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,279 | 778 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $3,571 | 778 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,572 | 2,175 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,966 | 1,562 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $91,017 | 18,095 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $122,854 | 14,105 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $138,708 | 14,867 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $140,661 | 10,972 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||